AAAAAA

   
Results: 1-25 | 26-33
Results: 1-25/33
Taxane-based chemotherapy for patients with carcinoma of unknown primary site
Authors: Greco, FA Gray, J Burris, HA Erland, JB Morrissey, LH Hainsworth, JD
Citation: Fa. Greco et al., Taxane-based chemotherapy for patients with carcinoma of unknown primary site, CANCER J, 7(3), 2001, pp. 203-212
Gemcitabine in the second-line therapy of patients with carcinoma of unknown primary site: A phase II trial of the Minnie Pearl Cancer Research Network
Authors: Hainsworth, JD Burris, HA Calvert, SW Willcutt, NT Scullin, DC Bramham, J Greco, FA
Citation: Jd. Hainsworth et al., Gemcitabine in the second-line therapy of patients with carcinoma of unknown primary site: A phase II trial of the Minnie Pearl Cancer Research Network, CANCER INV, 19(4), 2001, pp. 335-339
Weekly docetaxel in the treatment of elderly patients with advanced breastcancer: A Minnie Pearl Cancer Research Network phase II trial
Authors: Hainsworth, JD Burris, HA Yardley, DA Bradof, JE Grimaldi, M Kalman, LA Sullivan, T Baker, M Erland, JB Greco, FA
Citation: Jd. Hainsworth et al., Weekly docetaxel in the treatment of elderly patients with advanced breastcancer: A Minnie Pearl Cancer Research Network phase II trial, J CL ONCOL, 19(15), 2001, pp. 3500-3505
Paclitaxel and gemcitabine chemotherapy for advanced transitional-cell carcinoma of the urothelial tract: A phase II trial of the Minnie Pearl CancerResearch Network
Authors: Meluch, AA Greco, FA Burris, HA O'Rourke, T Ortega, G Steis, RG Morrissey, LH Johnson, V Hainsworth, JD
Citation: Aa. Meluch et al., Paclitaxel and gemcitabine chemotherapy for advanced transitional-cell carcinoma of the urothelial tract: A phase II trial of the Minnie Pearl CancerResearch Network, J CL ONCOL, 19(12), 2001, pp. 3018-3024
Weekly docetaxel as a single agent and in combination with gemcitabine in elderly and poor performance status patients with advanced non-small cell lung cancer
Authors: Hainsworth, JD Burris, HA Greco, FA
Citation: Jd. Hainsworth et al., Weekly docetaxel as a single agent and in combination with gemcitabine in elderly and poor performance status patients with advanced non-small cell lung cancer, SEMIN ONCOL, 28(3), 2001, pp. 21-25
Paclitaxel-based three-drug combinations for the treatment of small cell lung cancer: A review of the Sarah Cannon Cancer Center Experience
Authors: Hainsworth, JD Burris, HA Greco, FA
Citation: Jd. Hainsworth et al., Paclitaxel-based three-drug combinations for the treatment of small cell lung cancer: A review of the Sarah Cannon Cancer Center Experience, SEMIN ONCOL, 28(2), 2001, pp. 43-47
Docetaxel (Taxotere) in combination with radiation therapy and the potential of weekly administration in elderly and/or poor performance status patients with advanced non-small cell lung cancer
Authors: Hainsworth, JD Vokes, EE
Citation: Jd. Hainsworth et Ee. Vokes, Docetaxel (Taxotere) in combination with radiation therapy and the potential of weekly administration in elderly and/or poor performance status patients with advanced non-small cell lung cancer, SEMIN ONCOL, 28(1), 2001, pp. 22-27
Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma - Phase II trials of the Minnie Pearl Cancer Research Network
Authors: Hainsworth, JD Burris, HA Billings, FT Bradof, JE Baker, M Greco, FA
Citation: Jd. Hainsworth et al., Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma - Phase II trials of the Minnie Pearl Cancer Research Network, CANCER, 92(9), 2001, pp. 2391-2398
Paclitaxel and carboplatin adjuvant therapy alone or with radiotherapy forresected nonsmall cell lung carcinoma - A feasibility study of the Minnie Pearl Cancer Research Network
Authors: Greco, FA Burris, HA Gray, JR Raefsky, EL Dobbs, C Smith, S Rinaldi, D Morrissey, LH Erland, JB Litchy, S Hainsworth, JD
Citation: Fa. Greco et al., Paclitaxel and carboplatin adjuvant therapy alone or with radiotherapy forresected nonsmall cell lung carcinoma - A feasibility study of the Minnie Pearl Cancer Research Network, CANCER, 92(8), 2001, pp. 2142-2147
Paclitaxel, carboplatin, and long-term continuous infusion of 5-fluorouracil in the treatment of advanced squamous and other selected carcinomas - Results of a phase II trial
Authors: Hainsworth, JD Burris, HA Meluch, AA Baker, MN Morrissey, LH Greco, FA
Citation: Jd. Hainsworth et al., Paclitaxel, carboplatin, and long-term continuous infusion of 5-fluorouracil in the treatment of advanced squamous and other selected carcinomas - Results of a phase II trial, CANCER, 92(3), 2001, pp. 642-649
Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: A phase II trial of the Minnie Pearl Cancer Research Network
Authors: Hainsworth, JD Burris, HA Morrissey, LH Thomas, M Erland, JB Butts, JA Joseph, G Kalman, L Greco, FA
Citation: Jd. Hainsworth et al., Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: A phase II trial of the Minnie Pearl Cancer Research Network, CANCER J, 6(3), 2000, pp. 151-156
Gemcitabine and paclitaxel combination therapy in transitional cell carcinoma of the urothelium
Authors: Meluch, AA Burris, HS Greco, FA Hainsworth, JD
Citation: Aa. Meluch et al., Gemcitabine and paclitaxel combination therapy in transitional cell carcinoma of the urothelium, EUR J CANC, 36, 2000, pp. S30-S33
Carcinoma of unknown primary site: Phase II trials with docetaxel plus cisplatin or carboplatin
Authors: Greco, FA Erland, JB Morrissey, LH Burris III, HA Hermann, RC Steis, R Thompson, D Gray, J Hainsworth, JD
Citation: Fa. Greco et al., Carcinoma of unknown primary site: Phase II trials with docetaxel plus cisplatin or carboplatin, ANN ONCOL, 11(2), 2000, pp. 211-215
Management of patients with cancer of unknown primary site
Authors: Hainsworth, JD Greco, FA
Citation: Jd. Hainsworth et Fa. Greco, Management of patients with cancer of unknown primary site, ONCOLOGY-NY, 14(4), 2000, pp. 563
Gemcitabine, paclitaxel, and carboplatin for advanced non-small-cell lung cancer. (vol 14, pg 31, 2000)
Authors: Greco, FA Burris, HA Hainsworth, JD
Citation: Fa. Greco et al., Gemcitabine, paclitaxel, and carboplatin for advanced non-small-cell lung cancer. (vol 14, pg 31, 2000), ONCOLOGY-NY, 14(11), 2000, pp. 1521-1521
Overexpression of Her-2 in patients with poorly differentiated carcinoma or poorly differentiated adenocarcinoma of unknown primary site
Authors: Hainsworth, JD Lennington, WJ Greco, FA
Citation: Jd. Hainsworth et al., Overexpression of Her-2 in patients with poorly differentiated carcinoma or poorly differentiated adenocarcinoma of unknown primary site, J CL ONCOL, 18(3), 2000, pp. 632-635
Paclitaxel for limited-stage small-cell lung cancer
Authors: Greco, FA Hainsworth, JD
Citation: Fa. Greco et Jd. Hainsworth, Paclitaxel for limited-stage small-cell lung cancer, J CL ONCOL, 18(19), 2000, pp. 3453-3454
Rituximab as first-line systemic therapy for patients with low-grade lymphoma
Authors: Hainsworth, JD
Citation: Jd. Hainsworth, Rituximab as first-line systemic therapy for patients with low-grade lymphoma, SEMIN ONCOL, 27(6), 2000, pp. 25-29
Phase II trial evaluating triplet chemotherapy using gemcitabine, paclitaxel, and carboplatin in the treatment of patients with advanced non-small cell lung cancer
Authors: Burris, HA Hainsworth, JD Erland, JB Morrissey, LH Kalman, LA Hon, JK Scullin, DC Smith, SW Greco, FA
Citation: Ha. Burris et al., Phase II trial evaluating triplet chemotherapy using gemcitabine, paclitaxel, and carboplatin in the treatment of patients with advanced non-small cell lung cancer, SEMIN ONCOL, 27(1), 2000, pp. 9-13
Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinoma - A Minnie Pearl Cancer Research Network Phase II trial
Authors: Hainsworth, JD Burris, HA Litchy, S Morrissey, LH Barton, JH Bradof, JE Greco, FA
Citation: Jd. Hainsworth et al., Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinoma - A Minnie Pearl Cancer Research Network Phase II trial, CANCER, 89(2), 2000, pp. 328-333
Carcinoma of unknown primary site - Long term follow-up after treatment with paclitaxel, carboplatin, and etoposide
Authors: Greco, FA Burris, HA Erland, JB Gray, JR Kalman, LA Schreeder, MT Hainsworth, JD
Citation: Fa. Greco et al., Carcinoma of unknown primary site - Long term follow-up after treatment with paclitaxel, carboplatin, and etoposide, CANCER, 89(12), 2000, pp. 2655-2660
Gemcitabine and vinorelbine in the second-line treatment of nonsmall cell lung carcinoma patients - A minnie pearl cancer research network Phase II trial
Authors: Hainsworth, JD Burris, HA Litchy, S Erland, JB Hon, JK Brierre, JE Greco, FA
Citation: Jd. Hainsworth et al., Gemcitabine and vinorelbine in the second-line treatment of nonsmall cell lung carcinoma patients - A minnie pearl cancer research network Phase II trial, CANCER, 88(6), 2000, pp. 1353-1358
Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma
Authors: Hainsworth, JD Burris, HA Morrissey, LH Litchy, S Scullin, DC Bearden, JD Richards, P Greco, FA
Citation: Jd. Hainsworth et al., Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma, BLOOD, 95(10), 2000, pp. 3052-3056
Germ cell neoplasms and other malignancies of the mediastinum
Authors: Hainsworth, JD Greco, FA
Citation: Jd. Hainsworth et Fa. Greco, Germ cell neoplasms and other malignancies of the mediastinum, CANC TREAT, 2000, pp. 303-325
One-hour paclitaxel infusions: Review of safety and efficacy
Authors: Greco, FA Thomas, M Hainsworth, JD
Citation: Fa. Greco et al., One-hour paclitaxel infusions: Review of safety and efficacy, CA J SCI AM, 5(3), 1999, pp. 179-191
Risultati: 1-25 | 26-33